1. Home
  2. NBTB vs SYRE Comparison

NBTB vs SYRE Comparison

Compare NBTB & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$46.44

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$34.93

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
SYRE
Founded
1856
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
NBTB
SYRE
Price
$46.44
$34.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$51.00
$56.50
AVG Volume (30 Days)
211.5K
569.5K
Earning Date
01-26-2026
02-26-2026
Dividend Yield
3.19%
N/A
EPS Growth
12.12
N/A
EPS
3.33
N/A
Revenue
$678,339,000.00
N/A
Revenue This Year
$14.85
N/A
Revenue Next Year
$6.02
N/A
P/E Ratio
$13.93
N/A
Revenue Growth
21.71
N/A
52 Week Low
$37.31
$10.91
52 Week High
$49.18
$35.31

Technical Indicators

Market Signals
Indicator
NBTB
SYRE
Relative Strength Index (RSI) 65.66 57.61
Support Level $41.87 $30.92
Resistance Level $44.86 $34.07
Average True Range (ATR) 1.36 1.80
MACD 0.26 -0.03
Stochastic Oscillator 92.38 78.41

Price Performance

Historical Comparison
NBTB
SYRE

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: